A Path Analysis Modeling of the Interaction of AXII and/or AXIIR with the Changes in Cytokines and Myeloma Bone Disease

G
G. David Roodman, MD, PhD

Primary Investigator

Overview

The purpose of this research study is to learn if substances that cause bone destruction are increased in the blood or bone marrow.

Description

The purpose of this research study is to learn if substances that cause bone destruction are increased in the blood or bone marrow.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Multiple Myeloma
  • Age: Between 18 Years - 90 Years
  • Gender: All

Inclusion Criteria
Diagnosed with multiple myeloma

Exclusion Criteria
Currently pregnant
Are allergic to xylocaine
Currently enrolled in another research study
Additional Information:
Participants may be paid for their participation.

Updated on 18 Apr 2023. Study ID: 1204008459 (IUCRO-0373)

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center